Computer model helps cirrhosis patients get blood thinner doses right faster
NCT ID NCT07571460
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested whether a computer program (Simcyp) could help doctors choose the right starting dose of warfarin, a blood thinner, for 21 patients with liver cirrhosis and a blood clot in the portal vein. The goal was to see if the program helped patients reach a safe, effective level of blood thinning more quickly. The study found that using the program may help achieve the target blood thinning level within a few days, potentially reducing the risk of bleeding or clotting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kafrelsheikh University
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can liver damage predict how drugs behave?
- Better crystal ball for liver crisis: new scores put to the test
- Blood thinner may stop early cirrhosis from turning deadly โ a major trial puts it to the test
- Stick-On ultrasound patch could spot liver damage without a specialist